The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms
Open accessAbstract
Epidemic of diabetes, affecting about 3–5% of Western populations, is one of the main threats to human health in the 21st century (1). Changes in the human environment, behavior, and lifestyle have resulted in a dramatic increase in the incidence and prevalence of diabetes in people with genetic susceptibility to diabetes. The global number of people with diabetes was 151 million in 2000, and it is projected to increase to 221 million in 2010 (an increase of 46%) both in developed and developing countries (2). Chronic hyperglycemia leads to many long-term complications in the eyes, kidneys, nerves, heart, and blood vessels. Individuals with pre-diabetes, undiagnosed type 2 diabetes, and long-lasting type 2 diabetes are at high risk of all complications of macrovascular disease, coronary heart disease (CHD), stroke, and peripheral vascular disease. More than 70% of patients with type 2 diabetes die of cardiovascular causes (3). Therefore, the epidemic of type 2 diabetes will be followed by an epidemic of diabetes-related cardiovascular disease (CVD). Over the years, epidemiological studies have produced important information on the prevalence and incidence of diabetes complications in different populations. They have also given important information on different risk factors determining susceptibility to diabetes complications (Fig. 1). This information is crucial for mechanistic studies in physiology at the tissue level and for molecular biology studies at the cellular level. A good example is glycated hemoglobin. Several studies have indicated that glycated hemoglobin is associated with diabetes complications in prospective epidemiological studies. That information has been crucial for the planning of clinical trials to test the hypothesis that the treatment of chronic hyperglycemia leads to reduction in long-term diabetes complications. Moreover, information from epidemiology has led to several mechanistic studies and the elucidation of molecular level insights how insulin resistance and hyperglycemia lead to diabetes complications. …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Self-citationGlobal and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Amos, A. F., McCarty, D. J., & Zimmet, P. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199712)14:5+<s7::aid-dia522>3.0.co;2-r · Cited by 1,882
Coutinho, M., Gerstein, H. C., Wang, Y., & Yusuf, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.233 · Cited by 1,685
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411 · cited 1×
“An increased number of LDL particles might contribute to atherogenesis (39).”
BackgroundGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Self-citationAdiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
Steinberg, H. O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B., & Baron, A. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119636 · Cited by 761
Hyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 747
Self-citationNew Markers of Inflammation and Endothelial Cell Activation: Part I
Szmitko, P. E., Wang, C.-H., Weisel, R. D., de Almeida, J. R., Anderson, T. J., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000089190.95415.9f · Cited by 738
Impact of Diabetes on Mortality After the First Myocardial Infarction
Miettinen, H., Lehto, S., Salomaa, V., Mähönen, M., Niemelä, M., Haffner, S. M., Pyörälä, K., Tuomilehto, J., & The FINMONICA Myocardial Infarction Register Study Group (1998) · Diabetes Care · doi:10.2337/diacare.21.1.69 · Cited by 665
Fuller, J. H., Shipley, M. J., Rose, G., Jarrett, R. J., & Keen, H. (1983) · BMJ · doi:10.1136/bmj.287.6396.867 · Cited by 633
NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects
Kuusisto, J., Mykkänen, L., Pyörälä, K., & Laakso, M. (1994) · Diabetes · doi:10.2337/diab.43.8.960 · Cited by 591
Self-citationDiabetes Control and Complications Trial
Yue, D., Colagiuri, S., McElduff, A., & Silink, M. (1993) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb141357.x · Cited by 575
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
Mazzone, T., Chait, A., & Plutzky, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60768-0 · Cited by 545
Schramm, T. K., Gislason, G. H., Køber, L., Rasmussen, S., Rasmussen, J. N., Abildstrøm, S. Z., Hansen, M. L., Folke, F., Buch, P., Madsen, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.720847 · Cited by 538
Impaired Insulin-Mediated Skeletal Muscle Blood Flow in Patients With NIDDM
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1992) · Diabetes · doi:10.2337/diab.41.9.1076 · Cited by 470 · cited 1×
“We demonstrated that insulin-stimulated increase in leg glucose disposal and blood flow were coupled in a dose-dependent manner (23,24).”
BackgroundSelf-citationType 2 Diabetes as a “Coronary Heart Disease Equivalent”
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2901 · Cited by 452
Self-citationDiabetes mellitus as a prothrombotic condition
Grant, P. J. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01824.x · Cited by 443
Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2007) · Diabetes Care · doi:10.2337/dc06-1982 · Cited by 439
Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk
Juutilainen, A., Kortelainen, S., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2898 · Cited by 431
Self-citationInsulin and Risk of Cardiovascular Disease: A Meta-Analysis
Ruige, J. B., Assendelft, W. J. J., Dekker, J. M., Kostense, P. J., Heine, R. J., & Bouter, L. M. (1998) · Circulation · doi:10.1161/01.cir.97.10.996 · Cited by 391
Lehto, S., Rönnemaa, T., Haffher, S. M., Pyörälä, K., Kallio, V., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.8.1354 · Cited by 375
Self-citationDu, X., Edelstein, D., Obici, S., Higham, N., Zou, & Brownlee, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23354 · Cited by 347
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 336
Barrett, E. J., Eggleston, E. M., Inyard, A. C., Wang, H., Li, G., Chai, W., & Liu, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1313-z · Cited by 323
Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3252 · Cited by 307
Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Nondiabetic Men
Lempiäinen, P., Mykkänen, L., Pyörälä, K., Laakso, M., & Kuusisto, J. (1999) · Circulation · doi:10.1161/01.cir.100.2.123 · Cited by 293
Self-citationWeyer, C., Bogardus, C., & Pratley, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2197 · Cited by 292
Laakso, M., Sarlund, H., & Mykkänen, L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.223 · Cited by 286
Self-citationKadowaki, T., Yamauchi, T., & Kubota, N. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.070 · Cited by 272
Salmenniemi, U., Ruotsalainen, E., Pihlajamäki, J., Vauhkonen, I., Kainulainen, S., Punnonen, K., Vanninen, E., & Laakso, M. (2004) · Circulation · doi:10.1161/01.cir.0000150391.38660.9b · Cited by 264
Self-citationFesta, A., Hanley, A. J. G., Tracy, R. P., D’Agostino, R., & Haffner, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000091339.70120.53 · Cited by 232
Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention
Laakso, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00789.x · Cited by 230
Self-citationBock, G., Dalla Man, C., Campioni, M., Chittilapilly, E., Basu, R., Toffolo, G., Cobelli, C., & Rizza, R. (2006) · Diabetes · doi:10.2337/db06-0319 · Cited by 230
Vascular system: role of nitric oxide in cardiovascular diseases
Bian, K., Doursout, M., & Murad, F. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.06632.x · Cited by 229
Herrmann, J. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00347-9 · Cited by 226
Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2007) · Diabetes Care · doi:10.2337/dc06-1747 · Cited by 209
Self-citationKuusisto, J., Mykkänen, L., Pyörälä, K., & Laakso, M. (1994) · Stroke · doi:10.1161/01.str.25.6.1157 · Cited by 209
Self-citationAsymptomatic atherosclerosis and insulin resistance.
Laakso, M., Sarlund, H., Salonen, R., Suhonen, M., Pyörälä, K., Salonen, J. T., & Karhapää, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.1068 · Cited by 206
Self-citationNatali, A., Toschi, E., Baldeweg, S., Ciociaro, D., Favilla, S., Saccà, L., & Ferrannini, E. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1076 · Cited by 199
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2008) · Diabetes Care · doi:10.2337/dc07-2124 · Cited by 194
Self-citationLehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2000) · Diabetologia · doi:10.1007/s001250050023 · Cited by 193
Self-citationSoinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1700 · Cited by 186
Self-citationFesta, A., D’Agostino, R., Hanley, A. J. G., Karter, A. J., Saad, M. F., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1549 · Cited by 180
Moore, R. E., Navab, M., Millar, J. S., Zimetti, F., Hama, S., Rothblat, G. H., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000185320.82962.f7 · Cited by 173
Kilhovd, B. K., Juutilainen, A., Lehto, S., Rönnemaa, T., Torjesen, P. A., Hanssen, K. F., & Laakso, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0687-z · Cited by 165
Self-citationde Jager, J., Dekker, J. M., Kooy, A., Kostense, P. J., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000215951.36219.a4 · Cited by 163
Eddy, D. M., Schlessinger, L., Kahn, R., Peskin, B., & SCHIEBINGER, R. J. (2008) · Diabetes Care · doi:10.2337/dc08-0854 · Cited by 159
Laakso, M., Zilinskaite, J., Hansen, T. F., Boesgaard, T. W., Vänttinen, M., Stančáková, A., Jansson, P., Pellmé, F., Holst, J. J., Kuulasmaa, T., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0899-2 · Cited by 158
Self-citationInsulin resistance and coronary heart disease
Laakso, M. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199608000-00008 · Cited by 152
Self-citationFrankel, D. S., Meigs, J. B., Massaro, J. M., Wilson, P. W. F., O’Donnell, C. J., D’Agostino, R. B., & Tofler, G. H. (2008) · Circulation · doi:10.1161/circulationaha.108.792986 · Cited by 138
Asymptomatic atherosclerosis and insulin resistance.
MLaakso, HSarlund, RSalonen, MSuhonen, KPyörälä, TSalonen, J., & PKarhapää (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 133
Dandona, P., Aljada, A., Chaudhuri, A., & Bandyopadhyay, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030178 · Cited by 131
Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Type 2 Diabetic Men
Kuusisto, J., Lempiäinen, P. A., Mykkänen, L. M., & Laakso, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1629 · Cited by 109
Self-citationTemporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta
Otsuka, A., Azuma, K., Iesaki, T., Sato, F., Hirose, T., Shimizu, T., Tanaka, Y., Daida, H., Kawamori, R., & Watada, H. (2005) · Diabetologia · doi:10.1007/s00125-005-0005-6 · Cited by 85
C-Reactive Protein and 5-Year Survival in Type 2 Diabetes
Bruno, G., Fornengo, P., Novelli, G., Panero, F., Perotto, M., Segre, O., Zucco, C., Deambrogio, P., Bargero, G., & Perin, P. C. (2008) · Diabetes · doi:10.2337/db08-0900 · Cited by 66
Heinonen, S. E., Leppänen, P., Kholová, I., Lumivuori, H., Häkkinen, S.-K., Bosch, F., Laakso, M., & Ylä‐Herttuala, S. (2007) · Circulation Research · doi:10.1161/circresaha.107.154401 · Cited by 64
Self-citationRuotsalainen, E., Vauhkonen, I., Salmenniemi, U., Pihlajamäki, J., Punnonen, K. R. A., Kainulainen, S., Jalkanen, S., Salmi, M., & Laakso, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.021 · Cited by 44
Self-citationRoy, H., Bhardwaj, S., Babu, M., Kokina, I., Uotila, S. T. H., Ahtialansaari, T., Laitinen, T., Hakumäki, J. M., Laakso, M., Herzig, K., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5029fje · Cited by 35
Self-citation
Cited by
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
Self-citationHeart rate variability in type 2 diabetes mellitus: A systematic review and meta–analysis
Benichou, T., Pereira, B., Mermillod, M., Tauveron, I., Pfabigan, D., Maqdasy, S., & Dutheil, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195166 · Cited by 419
Cefalu, W. T., Kaul, S., Gerstein, H. C., Holman, R. R., Zinman, B., Skyler, J. S., Green, J. B., Buse, J. B., Inzucchi, S. E., Leiter, L. A., et al. (2018) · Diabetes Care · doi:10.2337/dci17-0057 · Cited by 363
Development of SGLT1 and SGLT2 inhibitors
Rieg, T., & Vallon, V. (2018) · Diabetologia · doi:10.1007/s00125-018-4654-7 · Cited by 377
Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?
Meza, C. A., La Favor, J. D., Kim, D.-H., & Hickner, R. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153775 · Cited by 323
Metadata
- Authors
- Laakso, M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-02-01
- Volume
- 33
- Issue
- 2
- Pages
- 442-449
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2019730753
- Cited by
- 300
- References
- 71
- FWCI
- 9.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.